Clinical Studies with Interleukin-2: An Overview
- 1 January 1992
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Second line therapy with low-dose subcutaneous interleukin-2 alone in advanced renal cancer patients resistant to interferon-alphaEuropean Journal Of Cancer, 1992
- Phase I Trial of Interleukin-2 plus Gamma-InterferonJournal of Immunotherapy, 1992
- Recombinant interleukin-2 in metastatic renal cell carcinoma—A European multicentre phase II studyEuropean Journal of Cancer and Clinical Oncology, 1991
- The out-patient use of recombinant human interleukin-2 and interferon alfa-2b in advanced malignanciesEuropean Journal of Cancer and Clinical Oncology, 1991
- Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2European Journal of Cancer and Clinical Oncology, 1991
- Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2[ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumorsEuropean Journal of Cancer and Clinical Oncology, 1989
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985